ArticleFrontiers in microbiology2018
Multidrug-Resistant
Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Genomic insights into multidrug resistance in clinicalFrontiers in microbiology · 2026Article
- First report ofASM case reports · 2025Article
- Genomic insights and epidemiology of mcr-1-Carrying Escherichia albertii isolated from agricultural soil in China.BMC genomics · 2025Article
- Genomic characterization of multidrug-resistantFrontiers in microbiology · 2025Article
- First Report on the Occurrence and Antibiotic Resistance Profile of Colistin-ResistantMicroorganisms · 2024Article
- Characterizing the gut microbiome of diarrheal mink under farmed conditions: A metagenomic analysis.PloS one · 2024Article
- Article
- Co-Harboring of Beta-Lactamases andAntibiotics (Basel, Switzerland) · 2023Article
- Pan-Genomics ofLife (Basel, Switzerland) · 2023Article
- Microbiology and Epidemiology ofMicroorganisms · 2022Review
- Molecular Characterization ofAntibiotics (Basel, Switzerland) · 2022Article
- Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial.Gut pathogens · 2022Article
- Comparative genomics of Chinese and international isolates ofMicrobial genomics · 2021Article
- Pan-Genome Reverse Vaccinology Approach for the Design of Multi-Epitope Vaccine Construct againstInternational journal of molecular sciences · 2021Article
- Preventive antibiotic treatment of calves: emergence of dysbiosis causing propagation of obese state-associated and mobile multidrug resistance-carrying bacteria.Microbial biotechnology · 2020Article
- Antimicrobial Susceptibility and Virulence ofFrontiers in microbiology · 2020Article
- The Evasive Enemy: Insights into the Virulence and Epidemiology of the Emerging Attaching and Effacing PathogenInfection and immunity · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.